BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,557,202 | -52.9% | 522,129 | -37.5% | 0.00% | -66.7% |
| Q2 2023 | $26,667,680 | +19.3% | 835,192 | +14.4% | 0.00% | +50.0% |
| Q1 2023 | $22,356,520 | -11.9% | 730,128 | +12.5% | 0.00% | -33.3% |
| Q4 2022 | $25,386,457 | +2.3% | 649,104 | +24.6% | 0.00% | 0.0% |
| Q3 2022 | $24,825,000 | +6.3% | 521,120 | -13.6% | 0.00% | 0.0% |
| Q2 2022 | $23,360,000 | -26.1% | 603,490 | +9.4% | 0.00% | -25.0% |
| Q1 2022 | $31,599,000 | -16.7% | 551,466 | +15.8% | 0.00% | -20.0% |
| Q4 2021 | $37,939,000 | -4.9% | 476,088 | +3.8% | 0.01% | 0.0% |
| Q3 2021 | $39,904,000 | +2.8% | 458,624 | +52.0% | 0.01% | 0.0% |
| Q2 2021 | $38,824,000 | +133.0% | 301,634 | +44.9% | 0.01% | +150.0% |
| Q1 2021 | $16,664,000 | +264.0% | 208,195 | +271.3% | 0.00% | +100.0% |
| Q4 2020 | $4,578,000 | +408.1% | 56,078 | +53.3% | 0.00% | – |
| Q3 2020 | $901,000 | +55.6% | 36,591 | +76.8% | 0.00% | – |
| Q2 2020 | $579,000 | +1830.0% | 20,700 | +1120.5% | 0.00% | – |
| Q1 2020 | $30,000 | – | 1,696 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |